Stockscreener 앱 받기
0.77
4.19%
0.031
시장 영업 전:
.78
0.01
+1.30%
전일 마감가:
$0.739
열려 있는:
$0.751
하루 거래량:
2.75M
Relative Volume:
0.65
시가총액:
$167.09M
수익:
-
순이익/손실:
$-90.60M
주가수익비율:
-1.2285
EPS:
-0.6268
순현금흐름:
$-68.88M
1주 성능:
+6.18%
1개월 성능:
-9.67%
6개월 성능:
-59.47%
1년 성능:
+51.75%
1일 변동 폭
$0.73
$0.77
1주일 범위
$0.68
$0.78
52주 변동 폭
$0.36
$2.35
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
명칭
Tenaya Therapeutics Inc
전화
415-865-2066
주소
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.77 | 167.09M | 0 | -90.60M | -68.88M | -0.6268 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-10 | 개시 | William Blair | Outperform |
| 2023-11-30 | 개시 | Leerink Partners | Outperform |
| 2022-06-15 | 개시 | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc 주식(TNYA)의 최신 뉴스
Tenaya Therapeutics Receives 'Moderate Buy' Rating from Brokerages - National Today
TNYA pulls back after hours following significant $1.13B deal-spurred rally - MSN
Tenaya Therapeutics (TNYA) Stock Analysis Report | Financials & Insights - Benzinga España
TNYA Stock Price, Quote & Chart | TENAYA THERAPEUTICS INC (NASDAQ:TNYA) - ChartMill
William Blair analysts confident on Tenaya Therapeutics (TNYA) product pipeline - MSN
Revenue Check: Is Tenaya Therapeutics Inc in a long term uptrendTreasury Yields & Community Consensus Stock Picks - baoquankhu1.vn
Investor Mood: Is Tenaya Therapeutics Inc stock a value trap2026 Levels & Real-Time Stock Price Movement Reports - baoquankhu1.vn
TNYA Technical Analysis | Trend, Signals & Chart Patterns | TENAYA THERAPEUTICS INC (NASDAQ:TNYA) - ChartMill
Pullback Watch: Is Tenaya Therapeutics Inc part of any ETF2026 Levels & Daily Profit Focused Stock Screening - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
Tenaya Therapeutics (TNYA) price target increased by 11.11% to 10.20 - MSN
William Blair Analysts Confident on Tenaya Therapeutics (TNYA) Product Pipeline - Yahoo Finance
Alnylam’s research pact worth up to $1.1B sends Tenaya higher - MSN
Tenaya Therapeutics, Inc. (TNYA) reports Q4 EPS of (12c), in line with consensus - MSN
Tenaya Therapeutics, Inc. (TNYA) Reports Q4 EPS of (12c), In Line with Consensus - Insider Monkey
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
How TN-301 Progress And Alnylam Deal At Tenaya Therapeutics (TNYA) Has Changed Its Investment Story - simplywall.st
Tenaya Therapeutics (NASDAQ:TNYA) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
What is Lifesci Capital's Estimate for TNYA Q1 Earnings? - MarketBeat
Outperform Maintained on Tenaya Therapeutics (TNYA) by Leerink and William Blair March 2026 - Meyka
TNYA Pulls Back After Hours Following Significant $1.13B Deal-Spurred Rally - Dailyhunt
Tenaya Therapeutics (TNYA) Valuation After TN-301 Data And New Alnylam Collaboration - simplywall.st
William Blair reiterates Outperform on Tenaya Therapeutics stock By Investing.com - Investing.com Australia
Leerink Partners reiterates Outperform on Tenaya stock at $2 - Investing.com UK
William Blair reiterates Outperform on Tenaya Therapeutics stock - Investing.com
Chardan Capital Reiterates Buy Rating for Tenaya Therapeutics (NASDAQ:TNYA) - MarketBeat
Tenaya Therapeutics Reports Promising 2025 Results, Advances Gene Therapy Programs, and Extends Cash Runway Into 2027 - Minichart
Tenaya Therapeutics (TNYA) Is Up 47.7% After Positive TN-301 DMD Data And Alnylam Deal - Yahoo Finance
Tenaya Therapeutics: Advancing Genetic Medicines and Small Molecule Therapies for Heart Disease Treatment - Minichart
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Bitget
Tenaya Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027 - TradingView
Tenaya Therapeutics (NASDAQ:TNYA) Issues Earnings Results, Meets Expectations - MarketBeat
Tenaya Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
TNYA: Clinical progress, Alnylam deal, and financing extend cash runway into 2027 - TradingView
Tenaya Therapeutics (NASDAQ: TNYA) narrows 2025 loss and extends cash runway to 2027 - Stock Titan
Tenaya Therapeutics Inc (TNYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):